[1]
“ Biopharmaceutics classification system: importance and inclusion in biowaiver guidance ”, Braz. J. Pharm. Sci., vol. 51, no. 1, pp. 143–154, Mar. 2015, doi: 10.1590/S1984-82502015000100015.